Total Funding
72
13
Total FundingSeries B raised
Growth Score
-10 pts
Heat Score
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
41598
NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.
- Jyothis George: Chief Medical OfficerPast Role: Amgen, Global Medical Vice President
- Daniel Swisher: Chief Executive OfficerPast Role: Jazz Pharmaceuticals, President and Chief Operating Officer
About the Company
NodThera is a Cambridge (UK) headquartered biotech engaged in innate immune/ inflammasome research. Their leading project is focused on developing inhibitors of the NLRP3 inflammasome for the treatment of inflammatory and neuroinflammatory diseases.
